𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mini-review: Overcoming tumor-intrinsic resistance to immune effector function

✍ Scribed by Ruth Ganss; Bernd Arnold; Günter J. Hämmerling


Book ID
102167679
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
191 KB
Volume
34
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In immunological cancer therapy, the current treatment emphasis is on the generation of effector cells that are specific for tumor antigens. However, there is a distressing lack of correlation between the induction of specific immunity in cancer patients and measurable clinical benefit. By studying mouse models of de novo tumorigenesis we are beginning to understand that the tumor itself, in particular the manifestation of a distinct tumor environment, impairs immune effector function; this concept is yet to be applied in human malignancy.